Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar PharmaD (91.02) Submitted: 10/26/2011 11:22:49 PM : Outperform Start Price: $40.29 ONXX Score: +12.66

Strong pipeline

Featured Broker Partners


Advertisement